
Pharma-Bio Serv, Inc.
OTC:PBSV
0.98 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 9.509 | 16.977 | 19.399 | 20.115 | 21.564 | 19.507 | 17.797 | 15.579 | 19.537 | 23.385 | 27.555 | 33.062 | 29.227 | 19.933 | 11.346 | 11.479 | 15.196 | 16.205 | 14.23 | 0.01 |
Cost of Revenue
| 6.993 | 11.91 | 14.517 | 14.755 | 14.898 | 13.33 | 12.111 | 11.968 | 13.753 | 15.9 | 18.582 | 21.229 | 19.355 | 13.072 | 7.954 | 7.64 | 9.407 | 9.381 | 8.116 | 0 |
Gross Profit
| 2.516 | 5.066 | 4.881 | 5.36 | 6.667 | 6.177 | 5.687 | 3.611 | 5.783 | 7.484 | 8.973 | 11.833 | 9.872 | 6.861 | 3.393 | 3.839 | 5.79 | 6.824 | 6.114 | 0.01 |
Gross Profit Ratio
| 0.265 | 0.298 | 0.252 | 0.266 | 0.309 | 0.317 | 0.32 | 0.232 | 0.296 | 0.32 | 0.326 | 0.358 | 0.338 | 0.344 | 0.299 | 0.334 | 0.381 | 0.421 | 0.43 | 1 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 4.599 | 5.036 | 5.875 | 5.703 | 6.109 | 5.762 | 4.138 | 3.409 | 2.783 | 2.923 | 3.136 | 3.176 | 2.031 | 0.04 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 3.804 | 3.949 | 3.707 | 9.214 | 4.441 | 4.48 | 4.599 | 5.036 | 5.875 | 5.703 | 6.109 | 5.762 | 4.138 | 3.409 | 2.783 | 2.923 | 3.136 | 3.176 | 2.031 | 0.04 |
Other Expenses
| 0 | 0 | 0.013 | 1.978 | 0.064 | 0.527 | 0.436 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.195 | 0 |
Operating Expenses
| 3.804 | 3.949 | 3.707 | 9.214 | 4.441 | 4.48 | 4.599 | 5.036 | 5.875 | 5.703 | 6.109 | 5.762 | 4.138 | 3.409 | 2.783 | 2.923 | 3.136 | 3.176 | 2.226 | 0.04 |
Operating Income
| -1.288 | 1.117 | 1.175 | -3.854 | 2.226 | 1.697 | 1.088 | -1.425 | -0.092 | 1.781 | 2.864 | 6.072 | 5.734 | 3.452 | 0.61 | 0.915 | 2.654 | 3.648 | 3.888 | -0.02 |
Operating Income Ratio
| -0.135 | 0.066 | 0.061 | -0.192 | 0.103 | 0.087 | 0.061 | -0.091 | -0.005 | 0.076 | 0.104 | 0.184 | 0.196 | 0.173 | 0.054 | 0.08 | 0.175 | 0.225 | 0.273 | -2 |
Total Other Income Expenses Net
| -754.16 | 0.57 | 0.013 | 1.978 | 0.064 | 0.527 | 0.436 | 0.044 | -0.112 | 0.011 | 0.014 | 0.005 | 0.022 | 0.012 | 0.011 | -0.019 | -0.145 | -0.31 | -0.393 | 0 |
Income Before Tax
| -755.448 | 1.687 | 1.188 | -1.876 | 2.29 | 2.223 | 1.524 | -1.411 | -0.204 | 1.793 | 2.878 | 6.076 | 5.756 | 3.464 | 0.621 | 0.896 | 2.509 | 3.337 | 3.495 | -0.02 |
Income Before Tax Ratio
| -79.443 | 0.099 | 0.061 | -0.093 | 0.106 | 0.114 | 0.086 | -0.091 | -0.01 | 0.077 | 0.104 | 0.184 | 0.197 | 0.174 | 0.055 | 0.078 | 0.165 | 0.206 | 0.246 | -2 |
Income Tax Expense
| 22.171 | 0.377 | 0.182 | 0.213 | 0.239 | 0.136 | 2.786 | 0.004 | 0.053 | 0.168 | 0.465 | 1.17 | 1.069 | 0.305 | 0.249 | 0.361 | 1.021 | 1.436 | 1.16 | 0 |
Net Income
| -0.778 | 1.31 | 1.007 | -2.089 | 2.051 | 2.087 | 1.28 | -1.415 | -0.257 | 1.625 | 2.414 | 4.906 | 4.687 | 3.159 | 0.372 | 0.535 | 1.488 | 1.901 | 2.335 | -0.02 |
Net Income Ratio
| -0.082 | 0.077 | 0.052 | -0.104 | 0.095 | 0.107 | 0.072 | -0.091 | -0.013 | 0.069 | 0.088 | 0.148 | 0.16 | 0.158 | 0.033 | 0.047 | 0.098 | 0.117 | 0.164 | -2 |
EPS
| -0.034 | 0.057 | 0.044 | -0.091 | 0.089 | 0.091 | 0.055 | -0.061 | -0.011 | 0.07 | 0.11 | 0.22 | 0.23 | 0.15 | 0.018 | 0.026 | 0.075 | 0.098 | 0.22 | -0.074 |
EPS Diluted
| -0.034 | 0.057 | 0.044 | -0.091 | 0.089 | 0.09 | 0.055 | -0.061 | -0.011 | 0.069 | 0.1 | 0.21 | 0.2 | 0.14 | 0.017 | 0.024 | 0.067 | 0.086 | 0.13 | -0.074 |
EBITDA
| -1.106 | 1.312 | 1.226 | -3.781 | 2.312 | 1.796 | 1.163 | -0.71 | 0.221 | 2.158 | 3.241 | 6.416 | 6.085 | 3.791 | 0.949 | 1.256 | 2.964 | 3.856 | 4.083 | -0.02 |
EBITDA Ratio
| -0.116 | 0.077 | 0.063 | -0.188 | 0.107 | 0.092 | 0.065 | -0.046 | 0.011 | 0.092 | 0.118 | 0.194 | 0.208 | 0.19 | 0.084 | 0.109 | 0.195 | 0.238 | 0.287 | -2 |